46
Participants
Start Date
January 31, 2012
Primary Completion Date
January 31, 2017
Study Completion Date
January 31, 2017
Memantine 10 mg capsule
"Memantine oral capsule was initiated at 5 mg/day at Randomization (Week 0), then titrated to 5 mg twice a day at Week 2, then increased to 10 mg in the morning and 5 mg in the evening at Week 3, and then to 10 mg twice a day (intervention dose) at Weeks 4-24. For the participants in the Placebo, then Memantine arm, the same titration schedule was maintained after the 4-week washout period (Week 28-52)."
Memantine-matched Placebo capsule
"Memantine-matched oral Placebo capsule was initiated at Randomization (Week 0) and maintained Weeks 0-24 in a manner consistent with the active drug titration schedule. The number of placebo capsules matched the number of active drug capsules at each titration checkpoint. For the participants in the Memantine, then Placebo arm, the same titration schedule was maintained after the 4-week washout period (Week 28-52)."
Aston Ambulatory Care Center, Allergy and Immunology, Dallas
National Institute on Drug Abuse (NIDA)
NIH
University of Texas Southwestern Medical Center
OTHER